Rocket Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Hello. This is Dave Lebowitz welcoming you to -- welcoming you again to the Morgan Stanley 18th Annual Global Healthcare Conference. I'm one of the biotech technology analysts here.
Before I get going, let me just run through the requisite disclosures. Please note that this webcast is from Morgan Stanley clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley research disclosure website at www.com/researchdisclosures (sic) [www.morganstanley.com/researchdisclosures]. If you have any questions, please reach out to your Morgan Stanley sales representative.
And with that, I'm happy to welcome into the next session from Rocket Pharmaceuticals, President and CEO, Gaurav Shah. Rocket is a development stage gene therapy company that's developing therapies for rare
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |